AbbVie
$166.41
24H
Market Cap
Volume
Supply
Price Chart
About AbbVie - ABBV
AbbVie Inc. is a global pharmaceutical company that originated as a spin-off of Abbott Laboratories in 2013, known for its research and development in biopharmaceuticals and a range of therapies, including immunology, oncology, and virology. Its notable products include Humira, one of the world's best-selling prescription drugs used to treat various autoimmune diseases.
What are AbbVie's core values and mission statement?
AbbVie Inc.'s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. Their core values emphasize pioneering, achieving, caring, and enduring as guiding principles in their pursuit to have a remarkable impact on people's lives.
Who founded AbbVie and when?
AbbVie Inc. was founded as a spin-off from Abbott Laboratories in 2013.
Who leads AbbVie?
As of the last update, Richard A. Gonzalez serves as the Chairman and Chief Executive Officer of AbbVie Inc.
Where is AbbVie located, and what is its base country?
AbbVie Inc. is headquartered in North Chicago, Illinois, and its base country is the United States.
On which exchanges is AbbVie traded?
AbbVie Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV."
Historical data
AbbVie (ABBV) Price Live Data
The live price of AbbVie (ABBV) is $166.41, with a trading volume of 5,043,871 in the last 24 hours. Wrapstocks updates the ABBV price in real-time. AbbVie is up 1.06% in the last 24 hours. The company has a live market cap of $294,653,886,464.00 and a supply of 1,770,650,120 ABBV stocks.
AbbVie (ABBV) is traded on New York Stock Exchange, and currently, the market is closed; trading will be resumed in 17 hours and 6 minutes.
